KalVista Pharmaceuticals Announced The UK Medicines And Healthcare Products Regulatory Agency Has Awarded The Promising Innovative Medicine Designation For Sebetralstat For On-demand Treatment Of Hereditary Angioedema
KalVista 制药公司宣布,英国药品和保健产品监管局已授予用于按需治疗遗传性血管性水肿的 Sebetralstat 具有前景的创新药物称号